PTC Therapeutics, Inc. Expected to Earn FY2028 Earnings of $0.39 Per Share (NASDAQ:PTCT)
PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) – Analysts at Leerink Partnrs issued their FY2028 EPS estimates for PTC Therapeutics in a research report issued on Monday, January 15th. Leerink Partnrs analyst J. Schwartz forecasts that the biopharmaceutical company will earn $0.39 per share for the year. The consensus estimate for PTC Therapeutics’ current full-year […]
More Stories
Canadian National Railway (TSE:CNR) Upgraded to “Strong-Buy” at Evercore ISI
Evercore ISI upgraded shares of Canadian National Railway (TSE:CNR – Free Report) (NYSE:CNI) from a hold rating to a strong-buy...
Invesco India ETF (PIN) To Go Ex-Dividend on December 23rd
Invesco India ETF (NYSEARCA:PIN – Get Free Report) declared a quarterly dividend on Thursday, January 11th,NASDAQ Dividends reports. Investors of...
Walmart (NYSE:WMT) Stock Price Up 0.3% – Time to Buy?
Walmart Inc. (NYSE:WMT – Get Free Report)’s share price was up 0.3% during mid-day trading on Thursday . The stock...
Smartkem Announces Pricing of $7.65 Million Offering for Public and Private Shares
Smartkem Inc. (NASDAQ: SMTK) recently disclosed its current report on Form 8-K, stating the pricing of a significant offering, as...
Ford Motor (NYSE:F) Trading 0.4% Higher – Should You Buy?
Shares of Ford Motor (NYSE:F – Get Free Report) rose 0.4% on Thursday . The company traded as high as...
Rigetti Computing (NASDAQ:RGTI) Stock Price Down 23.6% – Time to Sell?
Shares of Rigetti Computing, Inc. (NASDAQ:RGTI – Get Free Report) fell 23.6% during trading on Thursday . The stock traded...